fashion -WSS

fashion

author：explore 2025-10-03 00:38:41 - browse：9

Yichuan Cao/Sipa USA via AP Images

Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed.

The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.

Drugs like Trodelvy, known as antibody drug conjugates, are one of the hottest areas in oncology. The idea is that these medicines combine an antibody, which is triggered when it binds to a protein on a cancer cell, with a “payload” of chemotherapy that poisons the cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Raw milk easy to obtain despite bird flu warning, FDA interstate ban

entertainment

WSS

Poor hospice wound care hurts patients and families

Why medical students are struggling with mental health

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Astellas still sees hope in its gene therapy after four deaths

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

PBM reforms clear House panel

Wikipedia

fashion

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Novo Nordisk testing Wegovy against alcohol

How to save PrEP access — and even expand it

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Sports medicine is finally prioritizing gender equality

World's first CRISPR

In Memoriam: Notable people who died in 2023

Astellas still sees hope in its gene therapy after four deaths

BioMarin wins approval for gene therapy to treat hemophilia A

Abbott's new stent may help patients with peripheral artery disease

hotspot

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Cherokee Nation medical school graduates its first class

Congress must reauthorize a committee to support older Americans

In key trial, Verve's treatment lowers cholesterol levels in patients

Novo Nordisk testing Wegovy against alcohol

Free medical tuition alone isn't enough to close gaps in primary care

knowledge

entertainment

explore

knowledge